Clinical Research Directory
Browse clinical research sites, groups, and studies.
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
Sponsor: AstraZeneca
Summary
It is a retrospective observational study that will include female patients aged 18 years or older, who were treated between 2017 and 2024, in both public and private institutions, and identified as at high genetic risk by breast specialists and referred to a geneticist. The artificial intelligence-based tool to be used in this study is developed by the startup WeConecta, which will collect data via WhatsApp about the patients' family cancer history with the aim of predicting the genetic risk of developing breast cancer.
Official title: Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer (STAR-BREAST)
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
800
Start Date
2025-08-20
Completion Date
2026-08-11
Last Updated
2026-02-24
Healthy Volunteers
No
Conditions
Locations (3)
Research Site
Golania, Goiás, Brazil
Research Site
Porto Alegre, Rio Grande do Sul, Brazil
Research Site
Porto Alegre, Rio Grande do Sul, Brazil